BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 4202567)

  • 1. Rho (d) immune globulin (human).
    Med Lett Drugs Ther; 1974 Jan; 16(1):3-4. PubMed ID: 4202567
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prevention of Rh-sensitization in primiparas by means of human anti-rhesus-Rho (D) immunoglobulin].
    Verbitskiĭ MSh; Bashlaĭ AG; Morgulis NB
    Vopr Okhr Materin Det; 1978 Jan; 23(1):27-8. PubMed ID: 415432
    [No Abstract]   [Full Text] [Related]  

  • 3. [Intravenous anti-D immunoglobulins. (Prevention of anti-Rh immunization in France)].
    Jouvenceaux A
    Pathologica; 1972; 64(929):91-9. PubMed ID: 4210233
    [No Abstract]   [Full Text] [Related]  

  • 4. Is the recommended minimum dose of anti-D adequate considering the rise in obesity?
    Regan FA; Naftalin J; Springer V; Paterson-Brown S
    Transfus Med; 2008 Aug; 18(4):266-8. PubMed ID: 18783586
    [No Abstract]   [Full Text] [Related]  

  • 5. The use of Rh immune globulin: a review.
    Sutton GP; Jay A; Lim YS; Noland JE; Boral LI
    Indiana Med; 1988 Apr; 81(4):321-2. PubMed ID: 2834434
    [No Abstract]   [Full Text] [Related]  

  • 6. [Current viewpoints in the anti-D prevention of rhesus alloimmunization in the pregnant woman and of hemolytic disease of the newborn infant (a review of the literature)].
    Spasova K; Vŭlcheva B
    Akush Ginekol (Sofiia); 1986; 25(3):84-90. PubMed ID: 3019168
    [No Abstract]   [Full Text] [Related]  

  • 7. [Rhesus immunoprevention by means of immunoglobulin anti-D].
    Maas DH; Schneider
    Med Monatsschr; 1975 Aug; 29(8):340-7. PubMed ID: 813106
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevention of Rh-immunization in Sweden.
    Bartsch FK; Sandberg L; Unander M
    Pathologica; 1972; 64(929):111-4. PubMed ID: 4210412
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prevention of RH sensitization in Switzerland].
    Bamelli GP
    Pathologica; 1972; 64(929):101-3. PubMed ID: 4210411
    [No Abstract]   [Full Text] [Related]  

  • 10. On the immunologic basis of Rh immune globulin (anti-D) prophylaxis.
    Kumpel BM
    Transfusion; 2006 Sep; 46(9):1652-6. PubMed ID: 16965599
    [No Abstract]   [Full Text] [Related]  

  • 11. Some thoughts on assessing the effectiveness of passive immunization to Rh.
    Johnson JS; Clayton EM
    Obstet Gynecol; 1974 Apr; 43(4):571-5. PubMed ID: 4206100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the immunologic basis of Rh immune globulin (anti-D) prophylaxis.
    Kumpel BM
    Transfusion; 2006 Aug; 46(8):1271-5. PubMed ID: 16934058
    [No Abstract]   [Full Text] [Related]  

  • 13. Prophylaxis of maternal RH-sensitization by means of anti-D immunoglobulin.
    Petrov-Maslakov MA; Vasilyeva ZF; Matveyeva OF; Balasanyan IG; Sorina LI; Prigarnova TK
    Arch Immunol Ther Exp (Warsz); 1971; 19(3):343-8. PubMed ID: 4999474
    [No Abstract]   [Full Text] [Related]  

  • 14. [Our experience in the prevention of Rh immunization with immunoglobulin anti-D].
    Coletta A; Belletti F; Cardona A; Cammarota M; De Ninno F; Pennino G; Toro L; Miceli G
    Minerva Ginecol; 1974 Jul; 26(7):404-6. PubMed ID: 4213550
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunological aspects of the prevention of hemolytic disease of the newborn].
    Antonian AK
    Zh Eksp Klin Med; 1973; 13(6):44-9. PubMed ID: 4215267
    [No Abstract]   [Full Text] [Related]  

  • 16. [Evaluation of the Center for Rh-negative Mothers. Hospital Paula Jaraquemada (3 years)].
    Krug A; Bianchi R; Pérez N; Ilabaca G; Farías S; Rojas E
    Rev Chil Obstet Ginecol; 1981; 46(4):206-14. PubMed ID: 6099901
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevention of Rh hemolytic disease--ten years' clinical experience with Rh immune globulin.
    Freda VJ; Gorman JG; Pollack W; Bowe E
    N Engl J Med; 1975 May; 292(19):1014-6. PubMed ID: 804134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled trial of various anti-D dosages in suppression of Rh sensitization following pregnancy. Report to the Medical Research Council by the working party on the use of anti-D-immunoglobulin for the prevention of isoimmunization of Rh-negative women during pregnancy.
    Br Med J; 1974 Apr; 2(5910):75-80. PubMed ID: 4207590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mechanism of rosette formation between Rh (D)-positive erythrocytes and peripheral blood lymphocytes from Rh isoimmunized individuals. The role of surface micro-projections.
    Elson CJ; Bradley J; Howells RE
    Immunology; 1972 Jun; 22(6):1075-86. PubMed ID: 4624344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of Rh hemolytic disease of the newborn, United States, 1960-1979.
    Adams MM; Gustafson J
    Prog Clin Biol Res; 1981; 70():213-7. PubMed ID: 6273934
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.